Roxadustat: A promising treatment for anaemia in chronic kidney disease

from ResearchPod · host ResearchPod

More than one in seven people in the US have chronic kidney disease (CKD), making it one of the top causes of death. Anaemia is a common, though under-treated complication. Dr Robert Provenzano of Wayne State University and his team pooled together the results of three randomised clinical trials to investigate the efficacy and safety of of new treatment, Roxadustat, in managing the blood disease risks of CKD patients. Read the original article: doi.org/10.2215/CJN.16191020Read more in Research Features

Episode metadata supplied by the publisher feed · Published Aug 26, 2022

Embed this episode

Attribution link and audio player

Ready to play

Roxadustat: A promising treatment for anaemia in chronic kidney disease

0:00 9:35

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of ResearchPod?

This episode is 9 minutes long.

When was this ResearchPod episode published?

This episode was published on August 26, 2022.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this ResearchPod episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!